Power Law company profile

Clover Biopharmaceuticals

Biotech & Life Sciences · Chengdu, China · Founded 2007 Thoroughbred

Research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies

Valuation

$427M

Market cap · May/2026

Revenue

$5.3M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on Clover Biopharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Oceanpine Capital

Delos Capital

GL Ventures

Temasek

Lapam Capital

OrbiMed

Global footprint

Where Clover Biopharmaceuticals has talent and traffic

AI talent share

0.6% of workforce is AI talent
(1 of 160 staff)

Core AI00%

Other AI10.63%

Non-AI workforce15999.38%

Workforce by country

9 countries with
team presence

🇨🇳 China73.1%

🇺🇸 United States16.5%

🇫🇷 France3.8%

🇬🇧 United Kingdom1.3%

🇨🇦 Canada1.3%

Top 5 of 9 shown

Web traffic by country

1.4K monthly visits
across markets

🇺🇸 United States92.9%

🇯🇵 Japan7.1%

Top 2 markets shown

Market sentiment

What the market is saying about Clover Biopharmaceuticals

An AI-synthesized read of the highest-engagement posts about Clover Biopharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Clover Biopharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles